J. B. Chemicals & Pharmaceuticals Limited Stock

Equities

506943

INE572A01036

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:49 2024-04-29 EDT 5-day change 1st Jan Change
1,906 INR +2.27% Intraday chart for J. B. Chemicals & Pharmaceuticals Limited +6.72% +17.35%

Financials

Sales 2024 * 35.01B 420M 574M Sales 2025 * 40.58B 487M 665M Capitalization 296B 3.55B 4.85B
Net income 2024 * 5.64B 67.62M 92.43M Net income 2025 * 7.06B 84.67M 116M EV / Sales 2024 * 8.49 x
Net Debt 2024 * 1.32B 15.81M 21.61M Net cash position 2025 * 4.41B 52.91M 72.33M EV / Sales 2025 * 7.18 x
P/E ratio 2024 *
49.5 x
P/E ratio 2025 *
39.6 x
Employees 5,095
Yield 2024 *
0.64%
Yield 2025 *
0.75%
Free-Float 45.82%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on J. B. Chemicals & Pharmaceuticals Limited

1 day+2.27%
1 week+6.72%
Current month+15.57%
1 month+15.57%
3 months+12.48%
6 months+40.20%
Current year+17.35%
More quotes
1 week
1 779.40
Extreme 1779.4
1 910.00
1 month
1 652.55
Extreme 1652.55
1 910.00
Current year
1 473.95
Extreme 1473.95
1 935.00
1 year
914.65
Extreme 914.65
1 935.00
3 years
669.53
Extreme 669.525
1 935.00
5 years
153.50
Extreme 153.5
1 935.00
10 years
68.33
Extreme 68.325
1 935.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 20-10-04
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 59 20-08-30
Director/Board Member 40 11-06
Director/Board Member 48 21-02-09
More insiders
Date Price Change Volume
24-04-29 1,906 +2.27% 2,921
24-04-26 1,864 +0.48% 973
24-04-25 1,855 +1.69% 7,046
24-04-24 1,824 +2.30% 4,047
24-04-23 1,783 -0.16% 4,204

Delayed Quote Bombay S.E., April 29, 2024 at 06:00 am

More quotes
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,906 INR
Average target price
1,882 INR
Spread / Average Target
-1.29%
Consensus
  1. Stock Market
  2. Equities
  3. 506943 Stock